首页> 外国专利> Structural limit value biosynthesis, catalytic benefit reaction to produce three benefits of acrylic acid, food, nutrient or oil, hydrogenation method for producing 1.3-dichloroacrylic acid (DAG) and oil or fat

Structural limit value biosynthesis, catalytic benefit reaction to produce three benefits of acrylic acid, food, nutrient or oil, hydrogenation method for producing 1.3-dichloroacrylic acid (DAG) and oil or fat

机译:结构极限值的生物合成,催化作用反应以产生丙烯酸,食品,营养物或油脂的三种益处,氢化方法以生产1.3-二氯丙烯酸(DAG)和油脂

摘要

The biological activity synthesis method of structured fat includes the following steps: (a) providing a polypeptide with hydrolytic activity, in which the polypeptide is a separated, synthesized or re synthesized polypeptide with hydrolytic activity and the polypeptide in the following order: As described in SEQ ID No. 2, but also modified d61a, d61e, r72e, r72k, e116a, e116q, e116r, e116t, e116v, s33a, i151g, i151a, v163r, or d164r residues,O (II) a series of amino acids, as specified in SEQ ID 2, but also the change of amino acid residue i20l; v62s; g77p; v83c; d88h; y113g; e116t; e116g, h140k; k146s; i167s; L180E; e194m; a211q; s122y; g215c; g215v; g215w; a218h; a218s; v223a; 25a2m; or 25a2q; (b) Provide three triglyceride (tag) components;(c) In this condition, a residue of the hydrogenated peptide, anhydrides, is in the position of cyanuric acid (tag) S2,1. Production of 1,3-silicon dioxide (DAG);(d) R1 ester is provided; (E) a specific R1 hydrolysis is provided; and (f) a 1.3-dag of level (c) is associated with a R1 ester of level (d) and a specific R1 hydrolytic tissue of level (E), in which case the R1 hydrolytic tissue can specifically catalyze the disinfection of S2 position, thereby producing a structured lipid.
机译:结构化脂肪的生物活性合成方法包括以下步骤:(a)提供具有水解活性的多肽,其中该多肽是分离,合成或再合成的具有水解活性的多肽和该多肽,其顺序如下: SEQ ID No.2,但也修饰了d61a,d61e,r72e,r72k,e116a,e116q,e116r,e116t,e116v,s33a,i151g,i151a,v163r或d164r残基,O(II)一系列氨基酸SEQ ID NO:2中的氨基酸残基的变化; v62s; g77p; v83c; d88h; y113g; e116t; e116g,h140k; k146s; i167s; L180E; e194m; a211q; s122y; g215c; g215v; g215w; a218h; a218s; v223a; 25a2m;或25a2q; (b)提供三种甘油三酸酯(标签)成分;(c)在这种条件下,氢化肽的残基酸酐位于氰尿酸(标签)S2,1的位置。 1,3-二氧化硅(DAG)的生产;(d)提供R1酯; (E)提供特定的R1水解; (f)水平为(c)1.3的D1与水平为(d)的R1酯和水平为(E)的特定R1水解组织相关,在这种情况下,R1水解组织可以特异性催化S2的消毒位置,从而产生结构化脂质。

著录项

  • 公开/公告号AR105958A2

    专利类型

  • 公开/公告日2017-11-29

    原文格式PDF

  • 申请/专利权人 BUNGE OILS INC.;

    申请/专利号AR2016P102735

  • 发明设计人

    申请日2016-09-07

  • 分类号C12P7/64;C12N9/14;C12N9/20;

  • 国家 AR

  • 入库时间 2022-08-21 12:54:18

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号